Search Results

Drugs to Watch: Agents with New Mechanisms.

Subjects: DRUG therapy for schizophrenia;

Record details

ON THE MARKET NOVEL THERAPIES FOR CANCER AND RARE DISEASES.

Subjects: TUMOR treatment;

Record details

AI Drives Industry Response to FDA’s Project Optimus.

• Authors : Goswami, Sirj^1,2;
• Source: Applied Clinical Trials. May2024, Vol. 33 Issue 5, p18-19. 2p.

Record details

A Review of the Current Management and Burden of Prurigo Nodularis in the United States.

• Authors : Chisolm, Sarah S.^1,2

Subjects: *INFLAMMATION; *UNITED States

• Source: American Journal of Managed Care. 2023 Supplement, Vol. 29, pS63-S72. 10p.

Record details

Government announces 2023 False Claims Act recoveries: U.S. Department of Health and Human Services also is emphasizing cybersecurity.

• Authors : Rose, Rachel V.

• Source: Physicians Practice. Apr2024, p4-5. 2p.

Record details

Quo Vadis Analytical Procedure Development and Validation?

• Authors : Burgess, C.¹;
• Source: LC-GC Europe. Jul/Aug2022, Vol. 35 Issue 7, p279-284. 6p.

Record details

Analysis of Lipid Nanoparticles.

• Authors : Auclair, Jared R.¹;
• Source: LC-GC North America. Jun2023, Vol. 41 Issue 6, p216-219. 4p.

Record details

Don't overlook blepharoptosis in clinical practice.

• Authors : Brujic, Mile

• Source: Optometry Times. Dec2023, Vol. 15 Issue 12, p16-19. 4p.

Record details

Delineating the Nuts and Bolts of the USDA’s Hemp Testing Rules.

• Authors : HERNÁNDEZ, MARTHA

• Source: Cannabis Science & Technology. Jan/Feb2023, Vol. 6 Issue 1, p28-34. 5p.

Record details

Are Higher Standards for Expedited FDA Approvals Needed?

• Authors : HOLLASCH, MEGAN

• Source: OncologyLive. Feb2024, Vol. 25 Issue 4, p41-42. 2p.

Record details